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spread of some tumours than others. In conclusion, we suggest that a
more general term, such as vasogenesis (blood and lymphatic vessel
formation), may be more appropriate, unless the two processes of
angiogenesis and lymphagenesis are clearly distinguished.
JP vani Netten , SA Cann" , CA Maxwell' and RP Finegan'
'Special Development Laboratory, Royal Jubilee Hospital,
Capital Health Region V8R IJ8; 2Department ofBiology,
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Lymphagenesis and cancer metastasis - reply to the
letter from van Netten et al
Sir,
In their letter, van Netten et al made a point about the clear defini-
tion of the term for the neovascularization of lymphatic vessels.
They purported 'lymphagenesis' instead of 'lymphogenesis' or
'lymphangiogenesis' to describe the process of lymphatic vessel
formation. Obviously, uniformity of the term is needed. However,
the existence ofthe neovascularization oflymphatics in tumours is
not as yet well documented. In addition, the process ofthe forma-
tion ofa lymphatics-rich situation seems to be complicated. As we
mentioned in the Discussion, other functions that are different
from proliferation of the endothelial cells should be taken into
consideration for the relationship between vascular enthelial
growth factor (VEGF) and lymph node metastasis. For example, it
has been found that angiogenesis has a fundamental role in tumour
invasion (Skobe et al, 1997). If the neoformation of lymphatics
develops from pre-existing lymphatic vessels as blood vessels do,
the existence of pre-existing lymphatic endothelium might be
important for the formation of new lymphatics, and tumours with
high VEGF expression might be involved in the lymphatics-rich
situation in the course of spreading into surrounding tissue and
catching lymphatics. Recently, some reports have suggested that
the specific pathways involved in the formation of lymphatics are
different from those in haemangiogenesis (Wilting et al, 1996; Oh
et al, 1997). And among the VEGF family members, the function
of VEGF-C appears to extend to the lymphatic system as a ligand
for flt-4 (Kukk et al, 1996; Jeltsch et al, 1997, Oh et al, 1997).
Although our results suggest that the expression of VEGF has a
tendency to be greater in node-positive than in node-negative lung
cancer patients, the connection with the number of lymphatics is
not yet clear. In human primary cutaneous melanoma, de Waal et
al (1997) have recently reported the lack of 'lymphangiogenesis',
even in the presence of extensive haemangiogenesis, based on the
results of an immunohistochemical double-staining method. In
cutaneous melanoma, a positive relationship between VEGF
expression and lymph node metastasis has also been reported
(Salven et al, 1997). These results suggest that tumour cells with
high VEGF expression may elicit some function for nodal metas-
tasis independent of the number of lymphatics. We believe the
potential role of VEGF in lymphatic metastasis warrants further
study in this light. In conclusion, it is important that the termino-
logical definition is clarified; and the answer to the mechanisms
of lymphatic metastasis, including the neovascular formation of
lymphatic vessels, will provide the final definition ofthe term.
YOhta
First Department ofSurgery, Kanazawa Universitv School of
Medicine, Takara-machi 13-1, Kanazawa 920, Japan
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